These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8735716)

  • 41. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
    Terada T; Nakanuma Y
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: relationship to atypical reactive bile ductule.
    Asayama Y; Aishima S; Taguchi K; Sugimachi K; Matsuura S; Masuda K; Tsuneyoshi M
    Pathol Int; 2002 Apr; 52(4):300-6. PubMed ID: 12031086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 45. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
    Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
    Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.
    Rattanasinganchan P; Leelawat K; Treepongkaruna SA; Tocharoentanaphol C; Subwongcharoen S; Suthiphongchai T; Tohtong R
    World J Gastroenterol; 2006 Oct; 12(40):6500-6. PubMed ID: 17072981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Balsano C; Conti B; Arciello M
    Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma.
    Sugawara H; Yasoshima M; Katayanagi K; Kono N; Watanabe Y; Harada K; Nakanuma Y
    Histopathology; 1998 Aug; 33(2):145-53. PubMed ID: 9762547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
    Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
    Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
    Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions.
    Tsuneyama K; Sasaki M; Shimonishi T; Nakanuma Y
    Pathol Int; 2004 Mar; 54(3):181-6. PubMed ID: 14989741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis.
    Güllüoglu MG; Ozden I; Poyanli A; Cevikbas U; Ariogul O
    Ann Diagn Pathol; 2007 Feb; 11(1):34-8. PubMed ID: 17240305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report.
    Tanaka K; Honna T; Kitano Y; Kuroda T; Tanaka K; Morikawa N; Matsuda H; Kawashima N; Matsuoka K; Miyauchi J
    J Clin Pathol; 2005 Aug; 58(8):884-7. PubMed ID: 16049296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.
    Li Y; Zhang Y; Zheng Q
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):552-4. PubMed ID: 16463672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K; Wang HL
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
    Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
    Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
    Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
    In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
    Liu YF; Zhao R; Guo S; Wang XQ; Lian PL; Chen YG; Xu KS
    Ann Surg Oncol; 2011 Mar; 18(3):872-9. PubMed ID: 20848225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.